13F HOLDINGS REPORT (Amended)
Logos Global Management LP
Quarter ended Q2 2024 · Filed August 27, 2024 · Accession 0001172661-24-003755
Total Value
$1.24B
Positions
57
Other Managers
0
Confidential Omitted
No
Holdings (57)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 2,000,000 | $185.4M | 14.91% |
| 2 | SAREPTA THERAPEUTICS INC | SRPT | 500,000 | $79.0M | 6.35% |
| 3 | APELLIS PHARMACEUTICALS INC | APLS | 2,000,000 | $76.7M | 6.17% |
| 4 | IDEAYA BIOSCIENCES INC | IDYA | 1,700,000 | $59.7M | 4.80% |
| 5 | ARGENX SE | ARGX | 135,000 | $58.1M | 4.67% |
| 6 | MERUS N V | N5749R100 | 850,000 | $50.3M | 4.05% |
| 7 | REVOLUTION MEDICINES INC | RVMDW | 1,200,000 | $46.6M | 3.75% |
| 8 | STRUCTURE THERAPEUTICS INC | GPCR | 1,100,000 | $43.2M | 3.47% |
| 9 | DISC MEDICINE INC | IRON | 925,000 | $41.7M | 3.35% |
| 10 | OCULAR THERAPEUTIX INC | OCUL | 5,150,000 | $35.2M | 2.83% |
| 11 | OLEMA PHARMACEUTICALS INC | OLMA | 3,208,875 | $34.7M | 2.79% |
| 12 | VERA THERAPEUTICS INC | VERA | 950,000 | $34.4M | 2.76% |
| 13 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 750,000 | $33.0M | 2.65% |
| 14 | JANUX THERAPEUTICS INC | JANX | 750,000 | $31.4M | 2.53% |
| 15 | XENCOR INC | XNCR | 1,500,000 | $28.4M | 2.28% |
| 16 | SILENCE THERAPEUTICS PLC | SLNCF | 1,476,061 | $28.0M | 2.26% |
| 17 | SAREPTA THERAPEUTICS INC | SRPT | 150,000 | $23.7M | 1.91% |
| 18 | AKERO THERAPEUTICS INC | 00973Y108 | 800,000 | $18.8M | 1.51% |
| 19 | STRUCTURE THERAPEUTICS INC | GPCR | 450,000 | $17.7M | 1.42% |
| 20 | DESIGN THERAPEUTICS INC | DSGN | 5,032,501 | $16.9M | 1.36% |
| 21 | ANNEXON INC | ANNX | 3,300,000 | $16.2M | 1.30% |
| 22 | APELLIS PHARMACEUTICALS INC | APLS | 400,000 | $15.3M | 1.23% |
| 23 | IMMUNOVANT INC | IMVT | 575,000 | $15.2M | 1.22% |
| 24 | NUVALENT INC | NUVL | 195,000 | $14.8M | 1.19% |
| 25 | XENON PHARMACEUTICALS INC | XENE | 375,000 | $14.6M | 1.18% |
| 26 | IONIS PHARMACEUTICALS INC | IONS | 300,000 | $14.3M | 1.15% |
| 27 | STOKE THERAPEUTICS INC | STOK | 1,050,000 | $14.2M | 1.14% |
| 28 | ERASCA INC | ERAS | 5,900,000 | $13.9M | 1.12% |
| 29 | ENLIVEN THERAPEUTICS INC | ELVN | 595,000 | $13.9M | 1.12% |
| 30 | SPYRE THERAPEUTICS INC | SYRE | 575,000 | $13.5M | 1.09% |
| 31 | ENGENE HOLDINGS INC | ENGNW | 1,200,000 | $11.3M | 0.91% |
| 32 | CYBIN INC | HELP | 40,000,000 | $10.8M | 0.87% |
| 33 | SKYE BIOSCIENCE INC | SKYE | 1,301,518 | $10.4M | 0.84% |
| 34 | ELEVATION ONCOLOGY INC | 28623U101 | 3,850,000 | $10.4M | 0.84% |
| 35 | DYNE THERAPEUTICS INC | DYN | 265,000 | $9.4M | 0.75% |
| 36 | FULCRUM THERAPEUTICS INC | FULC | 1,500,000 | $9.3M | 0.75% |
| 37 | BIOHAVEN LTD | BHVN | 250,000 | $8.7M | 0.70% |
| 38 | RELAY THERAPEUTICS INC | RLAY | 1,300,000 | $8.5M | 0.68% |
| 39 | TREVI THERAPEUTICS INC | TRVI | 2,800,000 | $8.3M | 0.67% |
| 40 | ROCKET PHARMACEUTICALS INC | RCKTW | 350,000 | $7.5M | 0.61% |
| 41 | ANNEXON INC | ANNX | 1,500,000 | $7.3M | 0.59% |
| 42 | COMPASS PATHWAYS PLC | CMPS | 1,159,030 | $7.0M | 0.56% |
| 43 | AVALO THERAPEUTICS INC | AVTX | 539,079 | $6.7M | 0.54% |
| 44 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 4,700,000 | $4.7M | 0.38% |
| 45 | ATYR PHARMA INC | ATYR | 3,000,000 | $4.7M | 0.38% |
| 46 | ASTRIA THERAPEUTICS INC | 04635X102 | 500,000 | $4.5M | 0.37% |
| 47 | RAPPORT THERAPEUTICS INC | RAPP | 208,910 | $4.4M | 0.35% |
| 48 | NEXTCURE INC | NXTC | 2,500,000 | $4.0M | 0.32% |
| 49 | NEUMORA THERAPEUTICS INC. | NMRA | 300,000 | $2.9M | 0.24% |
| 50 | ALLAKOS INC | 01671P100 | 2,900,000 | $2.9M | 0.23% |
| 51 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 416,666 | $2.9M | 0.23% |
| 52 | APPLIED THERAPEUTICS INC | 03828A101 | 600,000 | $2.7M | 0.21% |
| 53 | CARTESIAN THERAPEUTICS INC | RNAC | 90,000 | $2.4M | 0.20% |
| 54 | UNICYCIVE THERAPEUTICS INC | UNCY | 3,469,927 | $1.7M | 0.14% |
| 55 | IO BIOTECH INC | IOBT | 493,827 | $577,778 | 0.05% |
| 56 | BOUNDLESS BIO INC | BOLD | 117,806 | $433,114 | 0.03% |
| 57 | NUVATION BIO INC | NUVB | 66,666 | $10,667 | 0.00% |